The February 2021 Registry Partners CTR Coding Break discusses clarifications and updates with the new SSDI version 2.0. The timing for recording lab tests is now listed as the first criteria within the general instructions. All lab values must be done no earlier than approximately three months before diagnosis and two prostate PSA lab value examples are provided. The new note 3 for the circumferential radial…
CTR Coding Break – Small Improvements, Big Impact
The January 2021 CTR Coding Break, Small Improvements, Big Impact: Tips for optimizing health for the CTR is a bit different than the usual topics you see on our channel. Entering the New Year, many of us set goals and resolutions in our personal lives, but what about our work lives? In this Coding Break, we will explore ways for the CTR to set new healthy…
CTR Coding Break – Bladder Cancer & Intravesical Therapy
The December CTR Coding Break reviews the topic ‘Bladder Cancer and Intravesical Therapy’. The slides provide a definition of what Intravesical therapy is, how the therapy is administered, and the different types of Intravesical therapy given. When a patient undergoes a TURBT followed by Intravesical therapy it’s important to code correctly the surgical treatment code(s) sequence along with correctly coding the chemotherapy or immunotherapy (BCG) treatment…
CTR Coding Break – Colon-Extent of Disease & Microsatellite Instability SSDI
The Registry Partners November 2020 CTR Coding Break reviews discusses extent of disease fields pertaining to colon, rectum, and rectosigmoid junction, as well as the site-specific data item, titled microsatellite instability (MSI). EOD Primary Tumor is used to code contiguous growth of the primary tumor, EOD Regional Nodes is used to code the regional lymph nodes involved, and EOD Mets is used to code the distant…